Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03225547
Recruitment Status : Recruiting
First Posted : July 21, 2017
Last Update Posted : February 28, 2018
Sponsor:
Information provided by (Responsible Party):
University of Chicago

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 2020
  Estimated Study Completion Date : September 2020